Laura Prendergast Analyst PerformanceManaging Director- Biotech Equity Research at Stifel NicolausLaura Prendergast is a stock analyst at Stifel Nicolaus focused in the medical sector, covering 10 publicly traded companies. Over the past year, Laura Prendergast has issued 18 stock ratings, including buy and hold recommendations. While full access to Laura Prendergast's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Laura Prendergast's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings20 Last 1 YearsBuy Recommendations88.24% 15 Buy RatingsCompanies Covered10 Unique Companies Ratings Distribution17RatingsDistribution of strong buy, buy, hold, and sell ratings by Laura Prendergast.RatingPercentageCount Strong Buy0.0%0 ratings Buy88.2%15 ratings Hold11.8%2 ratings Sell0.0%0 ratingsOut of 17 total stock ratings issued by Laura Prendergast at Stifel Nicolaus, the majority (88.2%) have been Buy recommendations, followed by 11.8% Hold.Best & Worst CallsBest Call0000.0%ERASMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ10 companiesLaura Prendergast, an analyst at Stifel Nicolaus, currently covers 10 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical9 companies90.0%Financial Services1 company10.0%Laura Prendergast of Stifel Nicolaus specializes in stock coverage within the Medical sector, with additional focus on Financial Services companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE9 companies90.0%INVESTMENT OFFICES1 company10.0% Laura Prendergast's Ratings History at Stifel Nicolaus Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsTNGXTango Therapeutics4/27/2026Boost Price Target$25.75$40.00Buy$0.0000.00% ROIERASErasca4/27/2026Boost Price Target$21.49$30.00Buy$0.0000.00% ROIRVMDRevolution Medicines4/20/2026Reiterated Rating$148.63Buy$0.0000.00% ROIERASErasca3/10/2026Set Price Target$15.58$20.00$0.0000.00% ROITNGXTango Therapeutics3/9/2026Boost Price Target$16.95$24.00Buy$0.0000.00% ROIOLMAOlema Pharmaceuticals2/11/2026Initiated Coverage$23.37$48.00Buy$0.0000.00% ROIBBOTBridgeBio Oncology Therapeutics2/10/2026Initiated Coverage$10.84$23.00Buy$0.0000.00% ROIERASErasca1/12/2026Set Price Target$6.23$10.00$0.0000.00% ROITNGXTango Therapeutics12/3/2025Initiated Coverage$9.57$15.00Buy$0.0000.00% ROIFHTXFoghorn Therapeutics12/3/2025Initiated Coverage$4.44$12.00Buy$0.0000.00% ROINUVLNuvalent11/17/2025Boost Price Target$110.17$135.00Buy$0.0000.00% ROICOGTCogent Biosciences11/10/2025Upgrade$33.30$40.00Buy$0.0000.00% ROIERASErasca11/6/2025Set Price Target$2.25$6.00$0.0000.00% ROINUVLNuvalent10/16/2025Initiated Coverage$92.75$115.00Buy$0.0000.00% ROIBDTXBlack Diamond Therapeutics10/15/2025Initiated Coverage$4.15$8.00Buy$0.0000.00% ROIRVMDRevolution Medicines10/15/2025Initiated Coverage$49.56$85.00Buy$0.0000.00% ROIERASErasca10/15/2025Initiated Coverage$2.49$4.00Buy$0.0000.00% ROICOGTCogent Biosciences10/15/2025Initiated Coverage$16.57$16.00Hold$0.0000.00% ROIERASErasca3/26/2025Initiated Coverage$1.48$5.00Outperform$00.0000.00% ROITHRDThird Harmonic Bio2/11/2025Reiterated Rating$4.65Market Perform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenWeiss RatingsUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
